What is Thyme Care?
Thyme Care operates as a high-growth oncology navigation leader, bridging the gap between patients and specialized care teams. By integrating 24/7 virtual support with data-driven clinical insights, the company addresses critical pain points in cancer treatment, including access, affordability, and care coordination. Its business model relies on strategic partnerships with health plans and oncology groups to streamline the patient journey, effectively reducing systemic healthcare costs while improving clinical outcomes. As a key player in the digital health transformation, Thyme Care leverages technology to ensure that oncology patients receive timely, personalized interventions throughout their treatment lifecycle.
How much funding has Thyme Care raised?
Thyme Care has raised a total of $496M across 5 funding rounds:
Unspecified
$22M
Series B
$60M
Series C
$95M
Stock/Share Issuance
$97M
Series D
$97M
Unspecified (2021): $22M with participation from Bessemer Venture Partners, AlleyCorp companies, Casdin Capital, Frist Cressey Ventures, and Andreessen Horowitz
Series B (2023): $60M led by Andreessen Horowitz, AlleyCorp, Frist Cressey Ventures, Foresite Capital, Town Hall Ventures, and Casdin Capital
Series C (2024): $95M supported by Concord Health Partners, Andreessen Horowitz, and Frist Cressey Ventures
Stock/Share Issuance (2025): $97M, investors not publicly disclosed
Series D (2025): $97M backed by Texas Oncology, Town Hall Ventures, Humana, Frist Cressey Ventures, AlleyCorp companies, CVS Health, Andreessen Horowitz, JPMorgan Chase, Concord Health Partners, Foresite Capital, and Memorial Hermann Health Plan
Key Investors in Thyme Care
Andreessen Horowitz
A prominent venture capital firm that invests in early-stage start-ups and established growth companies, providing significant strategic guidance to tech-forward healthcare enterprises.
Frist Cressey Ventures
A specialized venture capital firm dedicated to accelerating the growth of innovative companies that are transforming healthcare delivery and improving patient outcomes.
Casdin Capital
An investment firm with deep expertise in life science innovation, focusing on diagnostics and molecular information to support the next generation of healthcare pioneers.
What's next for Thyme Care?
With the successful completion of its latest funding round, Thyme Care is well-positioned to accelerate its market expansion and deepen its technological infrastructure. The company is expected to focus on scaling its navigation services to reach a broader demographic of health plan members, while simultaneously enhancing its predictive analytics capabilities. By leveraging the expertise of its diverse investor base—which includes major healthcare incumbents and specialized venture capital firms—Thyme Care is poised to solidify its role as an essential partner in the evolving value-based care landscape. Future growth will likely center on deepening integration with primary care networks and expanding its footprint in the oncology care community.
See full Thyme Care company page
